Cholesterol granulomas of the central nervous system are rare lesions and the petrous apex is the intracranial site most frequently involved. Cases of intracranial cholesterol granuloma have been reported associated with familial hypercolesterolemia and high serum lipid levels. With few cases reported in the literature, the pathogenesis of the event is until unclear.
Fig 1. (A) Axial CT Scan showing hypodense lesion in temporal lobe, with calcification. (B) Axial T1 MR showing temporal mass hyperintense to the cortex (lipid). (C) Axial T2 MR. (D) 5-month follow-up post-operative axial T1 MR.

DISCuSSIon
Intracranial cholesterol granulomata are rare lesions, and are thought to occur as a foreign body reaction against cholesterol crystals [1] [2] [3] [4] . Cholesterol granulomata occur in about 1 per 2-3 million population each year 5 . In the region of mastoid air cells, the mucosal swelling blockage of the pneumatic pathways to apical air cell system, leading to hypoxia and further tissue and blood cells necrosis. Trapped gas resorption results in a vacuum that triggers bleeding, and cholesterol crystals forms through anaerobic breakdown of blood products 3 . Another theory, the exposed marrow hypothesis, was postulated to explain the cholesterol granuloma formation 3 .
The petrous apex is the most intracranial site frequently involved by cholesterol granulomata 2, [5] [6] [7] , followed by orbital bones 4, 8, 9 . Further reports indicate that cholesterol granulomas account for 60% of petrous apex lesions 10 .There are cases of xanthomas in the third ventricle, including associated with colloid cyst 11 .
one case report was found concerned intracerebral localization of cholesterol granuloma 1 , in a patient with familial hypercolesterolemia and high serum lipid levels, who presented with an asymptomatic cholesterol granuloma of the brain. Intracranial cerebral cholesterol granulomata have not been associated with genetic hypercholesterolemia 5, 6 , with only one previous case linked to homozygous Fh 12 .
In the present case, the patient was not dislipidemic, neither history of familial hypercolesterolemia was present. There was no history of pregress neurologic illness, such as cerebral hemorhage or traumatic brain injury, wich could explain the presence of blood degradation products in the cerebral parenchyma. Thus, no risk factor could be assesed.
Imaging of the lesions with computed tomography and magnetic resonance imaging can help differentiate cholesterol granulomas from other lesions on the basis of a characteristic appearance. In general, the lesion is hyperintense in both T1 and T2-weight images, because of presence of lipid. A dark signal rim in T2, suggestive of hemosiderin, also could be seen.
The treatment of cholesterol granuloma is the surgical excision, with very low incidence of recurrence in cases with complete removal 4 .
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